3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
56
SPXC Quote, Financials, Valuation and Earnings
Last price:
$131.23
Seasonality move
:
8.08%
Day range:
$123.93 - $129.60
52-week range:
$116.05 - $183.83
Dividend yield:
0%
P/E ratio:
30.30x
P/S ratio:
3.06x
P/B ratio:
4.31x
Volume:
321.6K
Avg. volume:
325.4K
1-year change:
4.59%
Market cap:
$6B
Revenue:
$2B
EPS (TTM):
$4.25
Analysts' Opinion
-
Consensus RatingSPX Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $171.50, SPX Technologies has an estimated upside of 33.17% from its current price of $128.78.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $160.00 representing 100% downside risk from its current price of $128.78.
Fair Value
-
According to the consensus of 6 analysts, SPX Technologies has 33.17% upside to fair value with a price target of $171.50 per share.
SPXC vs. S&P 500
-
Over the past 5 trading days, SPX Technologies has underperformed the S&P 500 by -5.92% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SPX Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SPX Technologies has grown year-over-year revenues for 15 quarters straight. In the most recent quarter SPX Technologies reported revenues of $533.7M.
Earnings Growth
-
SPX Technologies has grown year-over-year earnings for 1 quarter straight. In the most recent quarter SPX Technologies reported earnings per share of $1.20.
Enterprise value:
6.4B
EV / Invested capital:
--
Price / LTM sales:
3.06x
EV / EBIT:
21.36x
EV / Revenue:
3.24x
PEG ratio (5yr expected):
0.25x
EV / Free cash flow:
25.94x
Price / Operating cash flow:
24.47x
Enterprise value / EBITDA:
16.38x
Gross Profit (TTM):
$799.4M
Return On Assets:
7.4%
Net Income Margin (TTM):
10.11%
Return On Equity:
15.52%
Return On Invested Capital:
10.01%
Operating Margin:
17.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.7B | $2B | $469.4M | $533.7M | |
| Gross Profit | $523.9M | $670M | $799.4M | $187.9M | $218.1M | |
| Operating Income | $64.8M | $222.7M | $311.9M | $63.9M | $92.9M | |
| EBITDA | $82.8M | $276.7M | $392.7M | $67.7M | $112.6M | |
| Diluted EPS | -- | $1.91 | $4.25 | $0.67 | $1.20 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $675.1M | $903.4M | $721.1M | $709.6M | $784.3M | |
| Total Assets | $2.3B | $2.6B | $1.9B | $2.4B | $2.7B | |
| Current Liabilities | $572.1M | $439.5M | $333.8M | $401.2M | $418.3M | |
| Total Liabilities | $1.7B | $1.5B | $851.7M | $1.2B | $1.3B | |
| Total Equity | $640.1M | $1.1B | $1.1B | $1.2B | $1.4B | |
| Total Debt | $412.4M | $246M | $246.8M | $558.3M | $614.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$136.8M | $208.5M | $285.9M | $126.5M | $166.5M | |
| Cash From Investing | -$66.1M | -$570.2M | -$284.5M | -$9M | -$7.2M | |
| Cash From Financing | -$38.9M | $309.6M | $53.1M | -$115.5M | -$123.8M | |
| Free Cash Flow | -$152.7M | $184.6M | $247.9M | $119.1M | $156.7M | |
SPXC
Sector
Market Cap
$6B
$600.1M
Price % of 52-Week High
70.05%
72.84%
Dividend Yield
0%
0%
Shareholder Yield
--
2.42%
1-Year Price Total Return
4.59%
-7.65%
Beta (5-Year)
1.220
0.782
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$134.58
200-day SMA
Sell
Level
$151.32
Bollinger Bands (100)
Sell
Level
137.94 - 163.32
Chaikin Money Flow
Buy
Level
96.6M
20-day SMA
Sell
Level
$135.41
Relative Strength Index (RSI14)
Sell
Level
38.01
ADX Line
Sell
Level
14.96
Williams %R
Neutral
Level
-70.4808
50-day SMA
Sell
Level
$143.15
MACD (12, 26)
Sell
Level
-3.03
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
93.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.4256)
Buy
CA Score
(Annual)
Level (0.3654)
Buy
Beneish M-Score
(Annual)
Level (-2.5229)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.9051)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.
Stock Forecast FAQ
In the current month, SPXC has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SPXC average analyst price target in the past 3 months is $171.50.
-
Where Will SPX Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that SPX Technologies share price will rise to $171.50 per share over the next 12 months.
-
What Do Analysts Say About SPX Technologies?
Analysts are divided on their view about SPX Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SPX Technologies is a Sell and believe this share price will drop from its current level to $160.00.
-
What Is SPX Technologies's Price Target?
The price target for SPX Technologies over the next 1-year time period is forecast to be $171.50 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SPXC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SPX Technologies is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SPXC?
You can purchase shares of SPX Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SPX Technologies shares.
-
What Is The SPX Technologies Share Price Today?
SPX Technologies was last trading at $131.23 per share. This represents the most recent stock quote for SPX Technologies. Yesterday, SPX Technologies closed at $128.78 per share.
-
How To Buy SPX Technologies Stock Online?
In order to purchase SPX Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 16.21% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.91% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 3.23% over the past day.
